Mixed Tumor, Mesodermal - 9 Studies Found Terminated : Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy : Uterine Neoplasms : 2007-07-19 : Drug: Carboplatin AUC 5 by vei Completed : A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide in Patients With MMT of the Uterus : Uterine Cancer : 2005-10-03 : Drug: Ifosfamide Ifosfamide 1. Terminated : Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer : Ovarian Cancer Primary Peritoneal Carcinoma Fallopian Tube : 2006-05-05 : Drug: Paclitaxel Other Name: T Terminated : Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus : Sarcoma : 2000-11-06 : Drug: topotecan hydrochloride Completed : Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus : Sarcoma : 1999-11-01 : Biological: filgrastim Drug: ifosfamide Completed : Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer : Ovarian Carcinosarcoma Recurrent Fallopian Tube Carcinoma : 2009-08-06 : Drug: Paclitaxel Given IV Completed : Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus : Mixed Tumor, Mullerian : 2007-07-16 : Drug: Carboplatin AUC 5 By Vei Completed : Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors : Tumor : 2006-12-18 : Drug: belinostat 300, 600, or Completed : Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma : Solid Tumor Lymphoma : 2006-12-18 : Drug: oral belinostat oral belinostat dosed once or twice daily at continuous and discontinuous dosing s